You are here

Article info

Article menu

Download PDFPDF

Neurodegeneration
Review
TDP-43 proteinopathies: a new wave of neurodegenerative diseases

Authors

  • Eva Maria Johanna de Boer Department of Neurology, Brain Centre Rudolf Magnus, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Viyanti K Orie Department of Neurology, Brain Centre Rudolf Magnus, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Timothy Williams Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Mark R Baker Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UKDepartment of Clinical Neurophysiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Hugo M De Oliveira Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Tuomo Polvikoski Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UKDepartment of Neuropathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Matthew Silsby Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Parvathi Menon Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Mehdi van den Bos Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Glenda M Halliday Brain and Mind Center, University of Sydney, Sydney, New South Wales, AustraliaDepartment of Neurology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Leonard H van den Berg Department of Neurology, Brain Centre Rudolf Magnus, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Ludo Van Den Bosch Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), University of Leuven, Leuven, BelgiumCenter for Brain & Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Philip van Damme Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), University of Leuven, Leuven, BelgiumCenter for Brain & Disease Research, Laboratory of Neurobiology, VIB, Leuven, BelgiumDepartment of Neurology, University Hospital Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Matthew C Kiernan Brain and Mind Center, University of Sydney, Sydney, New South Wales, AustraliaDepartment of Neurology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael A van Es Department of Neurology, Brain Centre Rudolf Magnus, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Steve Vucic Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Steve Vucic, The University of Sydney Westmead Clinical School, Sydney, NSW 2145, Australia; steve.vucic{at}sydney.edu.au
View Full Text

Citation

de Boer EMJ, Orie VK, Williams T, et al
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
Journal of Neurology, Neurosurgery & Psychiatry 2021;92:86-95.

Publication history

  • Received June 30, 2020
  • Revised August 28, 2020
  • Accepted September 13, 2020
  • First published November 11, 2020.
Online issue publication 
December 15, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.